TransOral Pharmaceuticals, Inc. Changes Name to Transcept Pharmaceuticals, Inc.
6/22/2007 11:29:21 AM
More...
|
TransOral Pharmaceuticals, Inc. Raises $40 Million in Series D Financing. Proceeds Will Be Used to Complete Intermezzo(TM) Phase 3 Clinical Trials and File NDA
3/6/2007 9:29:48 AM
More...
|
Hercules Technology Provides $10.0 Million Financing To TransOral Pharmaceuticals, Inc., A Specialty Pharmaceutical Company Developing Products For The Treatment Of Insomnia And Migraine
6/5/2006 10:39:53 AM
More...
|
TransOral Pharmaceuticals, Inc. Swallows $23M Series C
10/31/2005 1:16:47 PM
More...
|